Que retenir du bilan d’ENTRED 2007-2010 ?

Fagot-Campagna, A.; Weill, Alain; Paumier, A.; Poutignat, N.; Fournier, C.; Fosse, S.; Roudier, Candice; Romon, I.; Chantry, M.; Detournay, B.; Eschwège, É.; Rudnichi, Annie; Druet, C.; Halimi, Serge

doi:10.1016/s1957-2557(10)70047-x

Cited by 4 publications

(2 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other studies demonstrated similar results suggesting that a more regular lifestyle and less stress might help achieving better glucose control in T1DM [13][14][15]17]. Nevertheless, these studies were mostly conducted on small series of T1DM only, even though patients with T2DM remain the majority population in France and were advised strict self-quarantine as well [21,22]. Our study included 63.1% patients with T2DM, whose HbA1c levels decreased from a median of 7.6 to 7.3%, suggesting effective patient education for diabetes self-management even in people with long diabetes duration, several comorbidities and/or intensive insulin therapy.…”

Section: Discussionmentioning

confidence: 92%

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

et al. 2021

View full text Add to dashboard Cite

Introduction:The COVID-19 pandemic led to an international health crisis and restrictions. While the phenotype associated with COVID-19 severity in people with diabetes has rapidly been explored, the impact of restrictive measures, including lockdown, and tertiary care disruption on metabolic control and access to healthcare remained unknown. The aim of our study was to provide a comprehensive assessment on the overall management of diabetes during lockdown, including glucose control, weight changes, health care consumption and use of alternative forms of care such as telemedicine services, in a large sample of patients with type 1 (T1DM) or type 2 diabetes mellitus (T2DM). Methods: A prioritization of a care self-administered questionnaire was sent at the end of the first COVID-19 lockdown to all patients with diabetes routinely followed by diabetologists from the University Hospital of Nancy (France).

show abstract

Section: Discussionmentioning

confidence: 92%

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Le surpoids prévaut chez les hommes (30%) que chez les femmes (13%). SelonFAGOT-CAMPAGNA et al (2010), en France métropolitaine, 34% des patients étaient obèses (les femmes 18% et les hommes 16%) et 65% en surpoids (les femmes 24% et les hommes 41%). Nos résultats se rapprochent de ceux de la France.…”

unclassified

Profil épidémiologique, clinique et facteurs de risque de diabète sucré. Cas de l’Hôpital Provincial Général de Référence de Kinshasa

junior¹,

Mbaya²,

Amisi³

2021

CRP Journal

View full text Add to dashboard Cite

Introduction : Le diabète sucré est une affection métabolique chronique, fréquente, reconnue comme une épidémie mondiale. Méthodes : C’est une étude descriptive et rétrospective sur un échantillon de 50 patients à l’HPGRK sur une période de 2 ans. Résultats : Environ 60% étaient des femmes et 40% des hommes avec un sex ratio de 1,5/1. La tranche d’âge la plus touchée était comprise entre 52 et 62 ans, 94% des patients avaient un âge > 40 ans avec un âge moyen de 55,48±11,620. Le type 2 était prédominant avec 82,0%. 32% des patients étaient souvent obèses (12%) et en surpoids (20%) et 8% en dénutri. Les signes cardinaux de diabète sucré (44%) étaient les principales plaintes. La glycémie > 200 mg/dl (64%). Le facteur de risque de diabète revient aux antécédents familiaux de diabète sucré (56%) et les facteurs de risque cardiovasculaire à l’alcool (60%) et l’HTA. Le pied diabétique était la principale complication (42%). Conclusion : Le diabète sucré est fréquent. Il concerne souvent les femmes que les hommes, sujets de plus de 40 ans. Le pied diabétique est la complication la plus fréquente. Mots-clés : Diabète sucré, HTA, alcool, pied diabétique, glycémie

show abstract

The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach

et al. 2017

View full text Add to dashboard Cite

A better understanding of the economic burden of diabetes constitutes a major public health challenge in order to design new ways to curb diabetes health care expenditure. The aim of this study was to develop a new cost-of-illness method in order to assess the specific and nonspecific costs of diabetes from a public payer perspective. Using medical and administrative data from the major French national health insurance system covering about 59 million individuals in 2012, we identified people with diabetes and then estimated the economic burden of diabetes. Various methods were used: (a) global cost of patients with diabetes, (b) cost of treatment directly related to diabetes (i.e., ‘medicalized approach’), (c) incremental regression-based approach, (d) incremental matched-control approach, and (e) a novel combination of the ‘medicalized approach’ and the ‘incremental matched-control’ approach. We identified 3 million individuals with diabetes (5% of the population). The total expenditure of this population amounted to €19 billion, representing 15% of total expenditure reimbursed to the entire population. Of the total expenditure, €10 billion (52%) was considered to be attributable to diabetes care: €2.3 billion (23% of €10 billion) was directly attributable, and €7.7 billion was attributable to additional reimbursed expenditure indirectly related to diabetes (77%). Inpatient care represented the major part of the expenditure attributable to diabetes care (22%) together with drugs (20%) and medical auxiliaries (15%). Antidiabetic drugs represented an expenditure of about €1.1 billion, accounting for 49% of all diabetes-specific expenditure. This study shows the economic impact of the assumption concerning definition of costs on evaluation of the economic burden of diabetes. The proposed new cost-of-illness method provides specific insight for policy-makers to enhance diabetes management and assess the opportunity costs of diabetes complications’ management programs.Electronic supplementary materialThe online version of this article (doi:10.1007/s10198-017-0873-y) contains supplementary material, which is available to authorized users.

show abstract

Que retenir du bilan d’ENTRED 2007-2010 ?

Cited by 4 publications

References 7 publications

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

Profil épidémiologique, clinique et facteurs de risque de diabète sucré. Cas de l’Hôpital Provincial Général de Référence de Kinshasa

The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach

Contact Info

Product

Resources

About

Que retenir du bilan d’ENTRED 2007-2010 ?

Cited by 4 publications

References 7 publications

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study

Profil épidémiologique, clinique et facteurs de risque de diabète sucré. Cas de l’Hôpital Provincial Général de Référence de Kinshasa​

The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach

Contact Info

Product

Resources

About

Profil épidémiologique, clinique et facteurs de risque de diabète sucré. Cas de l’Hôpital Provincial Général de Référence de Kinshasa